Jolt Health Inc. Announces Availability of Meeting Materials
Vancouver, BC - Jolt Health Inc. (CSE: JOLT) (“Jolt” or the “Company”) announces that in connection with the ongoing Canada Post labour strike, the notice of meeting, management information circular, and form of proxy (the “Meeting Materials”) for the upcoming annual general and special meeting (the “Meeting”) of the shareholders (the “Shareholders”) of the Company, can be accessed under Jolt’s SEDAR+ profile on www.sedarplus.ca and through its website at www.jolt.health.
Registered Shareholders
The Company is encouraging Registered Shareholders to access the Meeting Materials electronically and vote online. Registered Shareholders can request copies of the Meeting Materials delivered via email by contacting Odyssey Trust Company (“Odyssey”), Jolt’s registrar and transfer agent, at 1-888-290-1175 (Toll-Free North America) or 1-587-885-0960 (Toll-Free International).
Beneficial Shareholders
Beneficial Shareholders should contact their broker/intermediary to obtain a copy of their voting instruction form or other proxy-related materials if not already provided.
Proxies and Questions
In all cases, Shareholders’ votes must be received not later than 9:00 a.m. (MST) on December 24, 2024 or not less than 48 hours (excluding Saturdays, Sundays and holidays) before the time for the holding of the Meeting or any adjournment thereof.
Shareholders with questions on voting may contact Odyssey at shareholders@odysseytrust.com or online at www.odysseytrust.com/contact.
About Jolt Health Inc.
Jolt Health Inc. (CSE – JOLT) is a leading life sciences company focused on healthcare, biotechnology and artificial intelligence. The company currently holds exclusive licenses for innovative therapeutic and pharmaceutical products throughout Europe, the UK, and North America. The company is committed to transforming the industry through research, collaboration, and technological advancement, sharping the future of healthcare worldwide.
For further information, please contact:
Gerald Tritt, CEO
Investor Relations
Phone: +1 (604) 343-2977
Email: info@jolt.health
www.jolt.health
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-looking statements
Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. All statements other than statements of historical fact are forward-looking statements, including, without limitation, statements regarding future financial position, business strategy, use of proceeds, corporate vision, proposed acquisitions, partnerships, joint-ventures, strategic alliances and co-operations, budgets, costs, and plans and objectives of or involving the Company. Such forward-looking information reflects management's current beliefs and is based on information currently available to management. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "forecasts", "predicts", "intends", "targets", "aims", "anticipates", "may", or "believes", or variations (including negative variations) of such words and phrases, or may be identified by statements to the effect that certain actions "may", "could", "should", "would", "might", or "will" be taken, occur, or be achieved. A number of known and unknown risks, uncertainties, and other factors may cause the actual results or performance to materially differ from any future results or performance expressed or implied by the forward-looking information. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of the Company including, but not limited to, the impact of general economic conditions, industry conditions, risks relating to epidemics or pandemics such as COVID-19, including the impact of COVID-19 on the Company's business, financial condition, and results of operations, lack of investor demand for Bitcoin and/or Bitcoin futures exchange-traded funds, and dependence upon regulatory approvals. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company does not assume any obligation to update or revise its forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by securities laws.